financetom
Business
financetom
/
Business
/
Eos Energy Enterprises Looks for Manufacturing Site Outside Mon Valley Works
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Eos Energy Enterprises Looks for Manufacturing Site Outside Mon Valley Works
Dec 20, 2024 8:39 AM

11:01 AM EST, 12/20/2024 (MT Newswires) -- Eos Energy Enterprises ( EOSE ) said Friday it is looking for a new manufacturing site in addition to its Mon Valley Works expansion as part of a strategy to meet the growing demand for renewable energy storage systems.

The company, which designs and manufactures zinc-based energy storage systems, said it launched the search for a new site while working to bring a second production line at Mon Valley into full operation.

Price: 4.30, Change: -0.03, Percent Change: -0.58

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Miner Asia Broadband's Q3 production up 40%
Miner Asia Broadband's Q3 production up 40%
Nov 12, 2025
Overview * Asia Broadband ( AABB ) reports 40% increase in Q3 gold and silver production from Q2 * AABB's gold and silver holdings value doubled, unrealized gain of $38 mln Outlook * Company committed to expanding gold and silver production and holdings quarterly Result Drivers * PRODUCTION INCREASE - AABB achieved a 40% increase in gold and silver production...
Corbus Pharma Q3 net loss widens to $23.3 mln
Corbus Pharma Q3 net loss widens to $23.3 mln
Nov 12, 2025
Overview * Corbus Pharmaceuticals ( CRBP ) Q3 net loss widens to $23.3 mln, driven by clinical development costs * Company completed $75 mln public offering, extending cash runway into 2028 * CRB-701 clinical data shows promising ORR in HNSCC, cervical, and bladder cancers Outlook * Company plans to meet FDA in Q1 2026 for CRB-701 data review * Corbus...
CorMedix Swings to Q3 Profit, Revenue Rises; Lifts Full-Year Guidance
CorMedix Swings to Q3 Profit, Revenue Rises; Lifts Full-Year Guidance
Nov 12, 2025
08:11 AM EST, 11/12/2025 (MT Newswires) -- CorMedix ( CRMD ) reported Q3 earnings Wednesday of $1.26 per diluted share, swinging from a loss of $0.05 a year earlier. One analyst polled by FactSet expected $0.95. Revenue for the quarter ended Sept. 30 was $104.3 million, compared with $11.5 million a year earlier. Analysts surveyed by FactSet expected $86 million....
Coya Therapeutics' Q3 net loss narrows
Coya Therapeutics' Q3 net loss narrows
Nov 12, 2025
Overview * Coya Therapeutics ( COYA ) Q3 net loss narrows to $2.1 mln from $4.0 mln last year * Company reports $3.6 mln collaboration revenue due to IND approval milestone * Coya completes $23 mln public offering, extending cash runway into 2H 2027 Outlook * Company expects to receive $4.2 mln milestone payment upon first patient dosing in ALS...
Copyright 2023-2026 - www.financetom.com All Rights Reserved